Resource library

Videos

Median Technologies: Imaging in Clinical Trials

At Median we’re determined to push the boundaries of what Imaging Technology can achieve, to help develop next-generation treatments with the potential to save or improve the lives of millions. We’re already transforming the use of medical images in Clinical Trials and patient care; extracting the highest quality, most advanced Imaging Biomarkers to set the standard for developing new therapies, diagnosing disease and treating patients. We’re helping biopharmaceutical organizations around the world make quicker, better-informed decisions, bringing new therapies closer every day.

20 May 2022

Median Technologies: Imaging in Clinical Trials

At Median we’re determined to push the boundaries of what Imaging Technology can achieve, to help develop next-generation treatments with the potential to…

See all videos

Brochures

Introducing Median Imaging Lab

Get more value from your oncology trials with transformative image insights, analyses and more

See all brochures

White papers

Understanding Novel Response Patterns of Immunotherapies

Immunotherapies display novel response patterns that affect the design of imaging based studies and the subsequent evaluation of imaging data. Applying traditional chemotherapy-based response assumptions to immunotherapy trials can result in inaccurate interpretation of response, premature therapy termination, and unnecessary removal of subjects from a trial. Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.

See all white papers

Case studies

How automation can improve data consistency/value, and streamline study workflow

See all case studies

Scientific publications

3D-Morphomics, Morphological Features on CT scans for lung nodule malignancy diagnosis

Elias MUNOZ [1,2], Pierre BAUDOT [1], Van-Khoa LE [1], Charles VOYTON [1], Benjamin RENOUST [1], Danny FRANCIS [1], Vladimir GROZA [1], Jean-Christophe BRISSET [1], Ezequiel GEREMIA [1], Antoine IANNESSI [1], Yan LIU [1], Benoit HUET [1] Afiliations: [1] Median Technologies, iBiopsy, Valbonne, France, [2] Laboratoire de Mathématiques de Lens - Université d'Artois, France.

Poster presented at the MICCAI conference in Singapore city, Singapore – September 18-22, 2022

See all scientific publications